SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-004815
Filing Date
2014-10-31
Accepted
2014-10-31 16:15:38
Documents
12
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q mstx-10q_20140930.htm 10-Q 882911
2 EX-10.1 mstx-ex101_2014093053.htm EX-10.1 36325
3 EX-31.1 mstx-ex311_201409309.htm EX-31.1 15073
4 EX-31.2 mstx-ex312_2014093010.htm EX-31.2 15115
5 EX-32.1 mstx-ex321_2014093011.htm EX-32.1 9985
6 GRAPHIC g20141030212640930462.jpg GRAPHIC 33288
  Complete submission text file 0001564590-14-004815.txt   4531232

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT mstx-20140930.xml EX-101.INS 624370
8 XBRL TAXONOMY EXTENSION SCHEMA mstx-20140930.xsd EX-101.SCH 38482
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mstx-20140930_cal.xml EX-101.CAL 33291
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mstx-20140930_def.xml EX-101.DEF 76076
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE mstx-20140930_lab.xml EX-101.LAB 241605
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mstx-20140930_pre.xml EX-101.PRE 184473
Mailing Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SUITE 150 SAN DIEGO CA 92130 8585520866
Mast Therapeutics, Inc. (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32157 | Film No.: 141186781
SIC: 2834 Pharmaceutical Preparations